Asia-Pacific Pingueculum Drugs Market – Industry Trends and Forecast to 2029

Asia-Pacific Pingueculum Drugs Market Analysis and Insights

A pingueculum is a typical conjunctival growth that is not malignant. The risk factors for the progression of pinguecula include exposure to ultraviolet light, trauma, wind, dust and sand, working outdoors for a long duration and advancing age.

The Asia-Pacific pingueculum drugs market report provides details of market share, new developments and product pipeline analysis, the impact of domestic and localized market players, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario, contact us for an analyst brief. Our team will help you create a revenue-impact solution to achieve your desired goal.

Data Bridge Market Research analyses that the Asia-Pacific pingueculum drugs market will grow at a CAGR of 8.5% during the forecast period of 2022 to 2029.

Market Definition

A pingueculum is a typical conjunctival growth that is not malignant. This is the transparent, delicate tissue that encircles the eye's white region (sclera). Pinguecula word is derived from the Latin word pinguis, which means "fat" or "grease." The growth occurs in the part of the conjunctiva that is exposed when the eye is open. The risk factors for the progression of pinguecula include exposure to ultraviolet light, trauma, wind, dust and sand, working outdoors for a long duration and advancing age. Individuals having a history of elevated UV exposure and those living closer to the equator have a higher incidence (outdoor work). According to certain research, males have a somewhat higher incidence than females, which could simply be due to a higher rate of UV exposure. It appears as a tiny, yellowish bump on the conjunctiva close to the cornea. It may emerge on either side of the cornea.

Asia-Pacific Pingueculum Drugs Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below

• Rising prevalence of pinguecula disorders and ocular pains

In 2020, according to the published article "Prevalence and associated factors of pinguecula in Western Turkey" by ULAKBİM Journal Systems, the study included 1443 individuals over the age of 20 years of Western Turkey, where it was found that 52.5% of people had pinguecula and out of that 52.5%, the prevalence of pinguecula was higher in males (58.4%), as compared to females (46.8%).

The prevalence of pinguecula disease keeps showing a surge in growth as several environmental and external factors worldwide. Chemical burns and flash burns cause significant and severe ocular pain due to irritations over the eye surface. Thus, the rising prevalence of pinguecula disorder and ocular pain is expected to drive the Asia-Pacific pingueculum drugs market in the forecast period.

• Rise in chronic UV radiation exposure due to ozone defect

In 2019, according to the published journal by "the Association for Research in Vision and Ophthalmology," it was stated that early pinguecula was found to have a prevalence of 39.5% in the temporal conjunctiva and 43.9% in the nasal conjunctiva respectively. That the reported amount of time spent on outdoor activities was 19.6% and 16.1% for less than 2 hours, 44.7% and 52.2% for 4 to 6 hours, respectively and 75.0% in both fields for more than 6 hours, indicates a positive correlation between the prevalence of pinguecula and the amount of time spent on outdoor activities and UV radiation exposure.

There is a correlation between increased exposure to UV and a higher prevalence of pinguecula. This demonstrates that there is a connection between the prevalence of pinguecula and exposure to sunlight. The ozone layer defect is also leading to an increase in the exposure of UV exposure which is increasing the prevalence of pinguecula disorder. Thus, it is expected to drive The Asia-Pacific pingueculum drugs market growth.

• Initiatives and plans to lessen the prevalence of eye illnesses

In 2020, The VISION 2020: The Right to Sight initiative was introduced in 1999 by the World Health Organization (WHO), Geneva, Switzerland and the International Agency for the Prevention of Blindness (IAPB), London, England. The Europe initiative VISION2020 seeks to end avoidable blindness by 2020 and focuses on the main causes of avoidable visual impairment.

According to the article by CDC (Centres for disease control and prevention), in 2022, through Vision Health Initiative (VHI) and diverse stakeholders, CDC initiated a coordinated national public health framework to prevent blindness and vision impairment.

The initiatives and plans are working as an opportunity for the market. Hence, initiatives and plans to lessen the prevalence of eye illness are expected to act as an opportunity for the growth of the Asia-Pacific pingueculum drugs market.

Restraints/Challenges

• Adverse effects of steroid eye drops

Ophthalmologists or optometrists are recommended by patients with mild to severe pinguecula for a thorough examination and prompt treatment. Most often, local tropical steroids, tropical immune modulators, lubricating ointment, gel, or drops are used to treat them.

Prednisolone is the topical steroid that is most frequently used to treat ocular pain. The prednisolone acetate ophthalmic suspension has below mentioned common adverse effects:

• Eyes sting, burn, or itch for one to two minutes after using this medicine
• Vision temporarily obscured
• Increased light sensitivity
• Visual alterations
• Experiencing a foreign object in your eyes
• Allergic responses

Lack of healthcare facilities for eye treatment

As per IntechOpen 2020 report, the prevalence of blindness and ocular disorders in high-income countries is 0.3 per 1000 people, but in low-income countries, the estimation is 1.5 per 1000. This shows the unmet need for ophthalmology care in low-income countries

Another major problem in low-income countries is the lack of awareness regarding ocular pain and other disorders. Many research studies report the high requirement of low-income countries for eye health care and their unmet needs are still gaining attention among many healthcare organizations. Hence, the poor healthcare facility for eye treatments in low and middle-income countries may act as restraints for the growth of the Asia-Pacific pingueculum drugs market.

Post-COVID-19 Impact on the Asia-Pacific Pingueculum Drugs Market

COVID-19 has negatively affected the market. Lockdowns and isolation during the pandemic complicate disease management and medication adherence. The lack of access to healthcare facilities for routine treatment and medication administration will further impact the market.

Recent Development

• In May 2022, Alcon announced the acquisition of EYSUVIS (loteprednol etabonate suspension) pharmaceutical eye drop from Kala Pharmaceuticals, Inc. The acquisition will complement the company's Systane family of eye drops which includes preservative-free formulations, among others
• In September 2022, Johnson & Johnson Vision Care, Inc. announced the launch of its new innovation of Acuvue Oasys Max–day contact lenses and its multifocal contact lenses for presbyopia. Additionally, these new contact lenses are with the new technology to meet the digitally intense lifestyle

Asia-Pacific Pingueculum Drugs Market Scope

Asia-Pacific pingueculum drugs market is categorized into seven notable segments based on drug type, treatment, formulation, mode of purchase, population type, end user and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Artificial Tears/Topical Lubricants
• Steroid Eye Drops
• Non-steroidal Eye Drops
• Others

Based on treatment, the Asia-Pacific pingueculum drugs market is segmented into artificial tears/topical lubricants, steroid eye drops, non-steroidal eye drops and others.

Formulation Type

• Eye Drops
• Eye Ointments
• Others

Based on formulation, the Asia-Pacific pingueculum drugs market is segmented into eye drops, eye ointments and others.

Mode of Purchase

• Prescription
• Over the Counter (OTC)

Based on mode of purchase, the Asia-Pacific pingueculum drugs market is segmented into prescription and over the counter (OTC).

Drug Type

• Branded
• Generics

Based on population type, the Asia-Pacific pingueculum drugs market is segmented into branded and generics.

Population Type

• Geriatric
• Adults

Based on population type, the Asia-Pacific pingueculum drugs market is segmented into geriatric and adults.

End User

• Hospitals
• Specialty Clinics
• Home Healthcare
• Others

Based on end user, the Asia-Pacific pingueculum drugs market is segmented into hospitals, specialty clinics, home healthcare and others.

Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Others

Based on the distribution channel, the Asia-Pacific pingueculum drugs market is segmented into retail pharmacies, hospital pharmacies, online pharmacies and others.

Pingueculum Drug Market Regional Analysis/Insights

Asia-Pacific pingueculum drugs market is analyzed and market size insights and trends are provided by country, drug type, treatment, formulation, mode of purchase, population type, end user and distribution channel as referenced above.

The countries covered in the Asia-Pacific pingueculum drugs market report are China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam and Rest of Asia-Pacific.

China is expected to dominate the Asia-Pacific pingueculum drugs because of initiatives and plans to lessen the prevalence of eye illness. The Asia-Pacific pingueculum drugs market is expected to grow due to the increasing prevalence of pingueculum in tropical areas and the growing geriatric population.

The country section of the report also provides individual market-impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of Asia-Pacific brands and the challenges faced due to high competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Pingueculum Drugs Market Share Analysis

Asia-Pacific pingueculum drugs market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to Asia-Pacific pingueculum drugs market.

Some of the major players operating in the Asia-Pacific pingueculum drugs market are Alcon Inc., Johnson & Johnson Services, Inc., Novartis AG, Akorn Operating Company LLC, Bausch & Lomb Incorporated, AbbVie Inc., Prestige Consumer Healthcare Inc., Spectra Vision Care, Théa Laboratories, Wellona Pharma, SAGER PHARMA, Maya Biotech Private Limited, EYERIS VISIONCARE Pvt. Ltd., Sylentis, Bayer AG, Zydus Group, Amneal Pharmaceuticals LLC, OASIS Medical, Similasan Corporation, Alcon and Santen Pharmaceutical Co., Ltd.

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by the DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Asia-Pacific Vs. Regional, and Vendor Share Analysis. Please request an analyst call in case of further inquiry.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market, and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you with data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

SKU-69473